The Knowledge Hub was founded to provide a rapid-publication service to the speciality chemicals industry. Covering life sciences, pharmaceuticals and cosmetics to agrochemicals and polymers, contract manufacturing to chemical regulations, and always with an eye on sustainability and corporate responsibility, this fast-growing, ever-evolving industry needs a one-stop site that provides up-to-date news and reviews from key opinion leaders and captains of industry. If you develop, manufacture, distribute, use or regulate chemical products that provide qualities or effects on which other industry sectors rely, this site is relevant to you.
The development and manufacture of small molecules, biologics, and advanced therapies draws on the talent, passion and experience of a wide range of professionals. At The Medicine Maker we bring those people into the limelight, showcasing the industry’s success stories and examining its biggest points of contention. Engaging content covers the entire spectrum of drug development, keeping all medicine makers up to date with the most pressing topics, trends and technologies driving the pharma industry forward.
From early stage portfolio decisions, clinical research and development to commercial planning and analysis, our proven solutions and global network of expert analysts and journalists deliver insider perspective, competitive intelligence and reliable forecasts that help you make highly informed clinical, regulatory and commercial decisions. The world’s top organizations in pharmaceutical, medtech, generics, consumer healthcare and clinical research rely on Informa Pharma Intelligence for its authority, accurate and forward-thinking analysis and intelligence on drugs, devices, markets, company’s, clinical trials, and regulatory insight, so they can work smarter, make better decisions faster, and achieve greater success.
Pharmaceutical Industry Review magazine is an objective information channel for professionals in the pharmaceutical / cosmetic / veterinary and related industries in Eastern Europe and EAEU countries.
IPT is designed to keep you informed of the latest ideas, cutting-edge technologies, and innovations shaping the future of pharmaceutical research, development, and manufacturing.
Free to view, this pharmaceutical technology journal brings together the views and expertise of over 600 renowned technical specialists. Each editorial section includes commercial online innovation features and case studies of technology in action, contributed by major industry suppliers. New product announcements and a calendar of pharmaceutical conferences and exhibitions ensure that you don’t miss out on the key events of the year.
A new malaria vaccine could be pivotal in the fight against the deadly disease. Scientists from Queen’s University Belfast have developed a virus-killing plastic that could make it harder for bugs, such as COVID-19, to spread in...Link up will utilise Brainomix’s AI software for the assessment of idiopathic pulmonary fibrosis
inPharma is a bimonthly B2B magazine on dietary supplements, OTC products, dermo-cosmetics and medical devices. It is appropriate medium for communicating informations on products and services primarily to pharmacists and pharmaceutical technicians. 5.000 copies are distributed free of charge in Croatia and in neighboring countries.
International Clinical Trials (ICT) is a specialist journal designed to provide global coverage of key topics pertinent to the clinical trials sector.
Published quarterly, the journal offers a platform of communication and information-sharing for executive and strategic decision makers, seeking out new trends and marketing opportunities, as well as putting a spotlight on the latest innovations coming to market. ICT is specifically designed to be of interest to those actively seeking to source services for improved efficiency in what is an increasingly competitive market.
Prompted by the synergies between trial operations and wider contract research and outsourcing issues, ICT joined forces with sister title European Pharmaceutical Contractor (EPC) in late-2015, in a move that brings added value to both brands. With EPC now an inserted edition within ICT, industry practitioners across these complementary subject areas now have unrivalled access to a wealth of shared views and analyses.
ICP Rivista dell’Industria Chimica, founded in 1973, has reached the leading position in technical press; that’s why become the monthly reference point for the decision makers of the chemical and pharma industry and process engineering in Italy. It is also the first multimedia magazine with podcasts, interactive insights, video tutorial and much more.
Global Business Reports (GBR) provides in-depth analyses and up-to-date insights into all aspects of the mining, energy, chemicals, life sciences and aerospace industries in countries all around the world. Our research includes face-to-face meetings with the main protagonists in the field to form an accurate picture of the actual situation on the ground. We introduce our readers to Who’s Who of each sector, as well as explaining Who thinks What? Best decisions depend upon the best information - which GBRs reports are prepared to provide.
The name is originated from the abbreviation of “E-commerce of chemical”. Echemi Group is a chemical supply chain service company headquartered in Hong Kong, providing chemical raw materials supply, research and analysis, digital solutions, marketing, distribution, logistics, e-commerce and after-sales services. Echemi Group Ranked 66 in ICIS Top 100 Chemical Distributors in 2020. At present, the product ranges mainly cover paint & coating, food & nutrition, fine chemical, pharmaceutical, and rubber & plastic. In the next decade, Echemi will focus on supply chain services, resources optimization and management efficiency, providing better products and services.
Regulators require excipient users to qualify their suppliers based on GMP / GDP audits and they have indicated that third party auditing of suppliers is acceptable if a creditable certification body issues certificates and audit reports by employing qualified auditors who are demonstrably credible in suitable GMP / GDP standards and in the needs of the pharmaceutical industry. EXCiPACT asbl is a non-profit organisation that owns and manages oversight of such an independent, high quality, third party Certification Scheme available to pharmaceutical excipient manufacturers and distributors worldwide.